Pure Global

Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder - Trial 2008-002067-14

Access comprehensive clinical trial information for 2008-002067-14 through Pure Global AI's free database. This phase not specified trial is sponsored by Wyeth Research and is currently status unknown. The study focuses on Major Depressive Disorder.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
2008-002067-14
Trial Details
EU Clinical Trials Register • 2008-002067-14
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder

Study Focus

Major Depressive Disorder

Sponsor & Location

Wyeth Research

Timeline & Enrollment

N/A

N/A

N/A

Primary Outcome

Number of Participants With Adverse Events AEs) and Serious Adverse Events (SAEs)-Baseline (Extension study) up to Extension study Week 29 Follow up visit

ICD-10 Classifications

Recurrent depressive disorder
Recurrent depressive disorder, unspecified
Depressive conduct disorder
Other recurrent depressive disorders
Recurrent depressive disorder, current episode moderate

Data Source

EU Clinical Trials Register

2008-002067-14

Non-Device Trial